Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Revolution Medicines (RVMD) Receivables - Other (2019 - 2020)

Revolution Medicines (RVMD) has 2 years of Receivables - Other data on record, last reported at $6.4 million in Q4 2020.

  • For Q4 2020, Receivables - Other fell 26.83% year-over-year to $6.4 million; the TTM value through Dec 2020 reached $6.4 million, down 26.83%, while the annual FY2020 figure was $6.4 million, 26.83% down from the prior year.
  • Receivables - Other reached $6.4 million in Q4 2020 per RVMD's latest filing, down from $9.3 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $9.3 million in Q3 2020 and bottomed at $6.4 million in Q4 2020.